Mitochondria are required for pro‐ageing features of the senescent phenotype

Clara Correia‐Melo(Universidade do Porto), Francisco DM Marques(Newcastle Hospitals - Campus for Ageing and Vitality), Rhys Anderson(Newcastle Hospitals - Campus for Ageing and Vitality), Graeme Hewitt(Newcastle Hospitals - Campus for Ageing and Vitality), Rachael N. Hewitt(Cancer Research UK Scotland Institute), John Cole(Cancer Research UK Scotland Institute), Bernadette Carroll(Newcastle Hospitals - Campus for Ageing and Vitality), Satomi Miwa(Newcastle Hospitals - Campus for Ageing and Vitality), Jodie Birch(Newcastle Hospitals - Campus for Ageing and Vitality), Alina Merz(Newcastle Hospitals - Campus for Ageing and Vitality), Michael D. Rushton(Newcastle Hospitals - Campus for Ageing and Vitality), Michelle Charles(Newcastle Hospitals - Campus for Ageing and Vitality), Diana Jurk(Newcastle Hospitals - Campus for Ageing and Vitality), Stephen W. G. Tait(Cancer Research UK Scotland Institute), Rafal Czapiewski(Newcastle Hospitals - Campus for Ageing and Vitality), Laura C. Greaves(Wellcome Centre for Mitochondrial Research), Glyn Nelson(Newcastle Hospitals - Campus for Ageing and Vitality), Mohammad Bohlooly‐Y(AstraZeneca (Sweden)), Sergio Rodríguez‐Cuenca(University of Cambridge), Antonio Vidal‐Puig(University of Cambridge), Derek A. Mann(Newcastle University), Gabriele Saretzki(Newcastle Hospitals - Campus for Ageing and Vitality), Giovanni Quarato(St. Jude Children's Research Hospital), Douglas R. Green(St. Jude Children's Research Hospital), Peter D. Adams(Cancer Research UK Scotland Institute), Thomas von Zglinicki(Newcastle Hospitals - Campus for Ageing and Vitality), Viktor I. Korolchuk(Newcastle Hospitals - Campus for Ageing and Vitality), João F. Passos(Newcastle Hospitals - Campus for Ageing and Vitality)
The EMBO Journal
February 4, 2016
Cited by 773Open Access
Full Text

Abstract

Cell senescence is an important tumour suppressor mechanism and driver of ageing. Both functions are dependent on the development of the senescent phenotype, which involves an overproduction of pro-inflammatory and pro-oxidant signals. However, the exact mechanisms regulating these phenotypes remain poorly understood. Here, we show the critical role of mitochondria in cellular senescence. In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis. Global transcriptomic analysis by RNA sequencing revealed that a vast number of senescent-associated changes are dependent on mitochondria, particularly the pro-inflammatory phenotype. Mechanistically, we show that the ATM, Akt and mTORC1 phosphorylation cascade integrates signals from the DNA damage response (DDR) towards PGC-1β-dependent mitochondrial biogenesis, contributing to aROS-mediated activation of the DDR and cell cycle arrest. Finally, we demonstrate that the reduction in mitochondrial content in vivo, by either mTORC1 inhibition or PGC-1β deletion, prevents senescence in the ageing mouse liver. Our results suggest that mitochondria are a candidate target for interventions to reduce the deleterious impact of senescence in ageing tissues.


Related Papers

No related papers found

Powered by citation graph analysis